Olema Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Good morning, everyone. Welcome, and thank you for joining us. Another great session here at the 2022 Jefferies' in-person Global Healthcare Conference. It's a great pleasure of mine to introduce the CEO of Olema Oncology, Sean Bohen, who gave a nice update today.
As you might be aware, there was an update and press release out issued this morning as well, which you can refer to. And I know Sean is going to go over some of that and we'll have some great Q&A.
Thank you very much, Michael. Thank you, everyone, for attending. It is nice to actually see people's faces. This is an exciting moment.
I'm going to do a very brief introduction. It's really one slide. Just to remind you, this is our forward-looking statement slide; you can go to our website and review it if you like. This is our slide. This is really also a recapitulation of what was presented in the press release this morning.
Just to orient people, Olema is a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
